Medical University Of Varna

Their core work

Medical University of Varna is a Bulgarian higher education institution with growing research capacity in translational medicine, medical imaging, and public health. Their work spans from developing physical breast phantoms using 3D printing for improving mammography and CT imaging, to community-based digital health interventions for chronic disease management. They have secured a major ERA Chair grant to build institutional strength in stem cell biology, signaling a deliberate push to become a competitive biomedical research center in Southeast Europe.

What they specialise in

How they've shifted over time

In 2014-2018, Medical University of Varna focused almost exclusively on research capacity building through recurring Researchers' Night events (K-TRIO series) and joined its first health research consortium (Feel4Diabetes). From 2019 onward, a clear shift occurred: they secured their first coordinator roles, won a major ERA Chair in stem cell biology, and expanded into medical imaging technology and digital primary healthcare. The trajectory shows an institution transitioning from a passive participant in science outreach to an active research leader building domain-specific expertise.

MU-Varna is investing heavily in building independent research capacity in biomedical sciences, positioning itself as a future coordinator of clinical and translational research projects.

How they like to work

MU-Varna has been predominantly a participant (5 of 7 projects) but took on coordinator roles in its two most ambitious projects (TRANSTEM and PHENOMENO), suggesting growing confidence and institutional maturity. With 39 unique partners across 14 countries, they maintain a broad European network rather than relying on a small circle of repeat collaborators. Their consortium sizes and funding scheme mix (CSA, RIA, MSCA-RISE) indicate flexibility — comfortable in both large multi-partner actions and focused research teams.

MU-Varna has collaborated with 39 distinct partners across 14 countries, building a moderately wide European network. As a Bulgarian institution, their partnerships likely span both Western European research leaders and regional neighbors in Southeast Europe.

What sets them apart

MU-Varna stands out as one of few Bulgarian medical universities that successfully coordinated H2020 research projects, not just participated. Their combination of medical imaging physics (3D-printed breast phantoms), stem cell biology, and digital health creates an unusual interdisciplinary profile for an institution in the Widening countries. For consortium builders seeking a capable partner in Bulgaria — particularly for health, digital health, or medical device topics — MU-Varna brings both research ambition and eligibility advantages under Widening participation rules.

Highlights from their portfolio

• TRANSTEM
  Their largest project (EUR 2.5M) and an ERA Chair — a prestige grant designed to transform the institution's research capacity in stem cell biology.
• PHENOMENO
  Coordinated project combining 3D printing, medical physics, and imaging — an unusually technical topic for a medical university, showing engineering-grade research capability.
• DigiCare4You
  Their entry into digital health and primary care innovation, addressing diabetes and hypertension with m-health tools at community scale.